ImaginAb Announces New Supply Agreement to Supply Genmab A/S with its investigational CD8 ImmunoPET agent

/PRNewswire/ -- ImaginAb, Inc., a market leading global biotechnology company focused on developing next generation ImmunoPET imaging agents and therapeutic...

Related Keywords

Jim Pallotta ,Ian Wilson ,Cycad Group ,Imaginab Inc ,Parker Institute For Cancer Immunotherapy ,Raptor Group ,Prnewswire Imaginab Inc ,Chief Executive Officer ,Adage Capital ,Norgine Ventures ,Parker Institute ,Imaginab ,